4155 — OK Biotech Co Cashflow Statement
0.000.00%
Last trade - 00:00
- TWD3.78bn
- TWD3.75bn
- TWD1.19bn
- 39
- 16
- 52
- 23
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Net Income/Starting Line | 143 | 152 | 46.1 | 176 | 8.03 |
Depreciation | |||||
Amortisation | |||||
Non-Cash Items | -22.1 | -27.4 | -11.3 | 44.8 | 8.5 |
Unusual Items | |||||
Equity in Net Earnings/Losses | |||||
Other Non-Cash Items | |||||
Changes in Working Capital | -118 | -26.7 | -68.9 | -47.8 | -89.1 |
Change in Accounts Receivable | |||||
Change in Inventories | |||||
Change in Prepaid Expenses | |||||
Change in Other Assets | |||||
Change in Accounts Payable | |||||
Change in Other Liabilities | |||||
Other Operating Cash Flow | |||||
Cash from Operating Activities | 45.2 | 148 | 21.9 | 241 | 2.93 |
Capital Expenditures | -78 | -79.8 | -86.5 | -294 | -437 |
Purchase of Fixed Assets | |||||
Purchase / Acquisition of Intangibles | |||||
Other Investing Cash Flow Items | -7.54 | -47.2 | -88 | 0.011 | 78.7 |
Sale of Fixed Assets | |||||
Sale/Maturity of Investment | |||||
Change in Net Investments | |||||
Purchase of Investments | |||||
Other Investing Cash Flow | |||||
Cash from Investing Activities | -85.5 | -127 | -174 | -294 | -358 |
Financing Cash Flow Items | 0.5 | 5.29 | 0 | — | — |
Other Financing Cash Flow | |||||
Total Cash Dividends Paid | |||||
Net Issuance / Retirement of Stock | |||||
Net Issuance / Retirement of Debt | |||||
Cash from Financing Activities | 185 | 216 | 186 | 50.3 | 82.1 |
Foreign Exchange Effects | |||||
Beginning Cash Balance | |||||
Ending Cash Balance | |||||
Net Change in Cash | 148 | 234 | 33.1 | -3.44 | -273 |